About BioLingus
Biolingus is a Swiss biotech company spearheading the development of oral (sublingual) and mucosal delivery of peptides and proteins. Our technology is derived from applied bio-engineering, resulting in novel bio-mimetic materials. It is a cutting-edge and mature solution for oral formulations not only for peptides but also proteins, novel protein scaffolds, vaccines, immunotherapies, enzymes and also very hydrophobic small molecules. The company focuses the development of its own products on treatment of chronic diseases, such as diabetes and inflammatory diseases. In addition to that, a particular area of interest is oral immunotherapy, as our technology has shown an outstanding performance in this area. BioLingus’ main office is in Switzerland, and we have a satellite company in Hong Kong.
|
|
|
1-10 employees
View all BioLingus employees
|
|
IT Services and IT Consulting
|
|
July
|
BioLingus Alternatives
Frequently Asked Questions about BioLingus
Yves Decadt is the CEO of BioLingus. To contact Yves Decadt email at [email protected].
The decision makers in BioLingus are Guy Vergnault, Qu Ricky, Thomas Saiying Ko, etc. Click to Find BioLingus decision makers emails.
BioLingus Staff Directory
Search BioLingus Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
